Post-Operative Pain (POP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Post-Operative Pain (POP) Marketed and Pipeline Drugs Report Overview
Post-operative pain (POP) is considered a form of acute pain due to surgical trauma with an inflammatory reaction and initiation of an afferent neuronal barrage. There could also be some generalized body pain before the operation with aggravation after the operation. This type of operation often needs complete or partial anesthesia. Disturbances in the channels and collaterals or the internal organs may be the cause.
Key Mechanisms of Action (Marketed) | · Enzyme Inhibitor
· Receptor Agonist · Receptor Antagonist · Transporter Inhibitor · Ion Channel Blocker |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
The post-operative pain (POP) marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, and pricing and reimbursement of therapy in major countries. Furthermore, the report analyzes late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) for post-operative pain.
The report also provides actionable insights into the clinical and commercial landscapes of post-operative pain (POP)drugs, M&A deals, and market catalysts. These critical data will help you develop and design your in-licensing and out-licensing strategies. Furthermore, identify companies with the most robust pipelines to create smart business goals.
Key Mechanisms of Action (Pipeline) | · Enzyme Inhibitor
· Receptor Agonist · Ion Channel Blocker · Receptor Antagonist · Transporter Inhibitor |
Key Molecule Types (Pipeline) | · Small Molecule
· Biologic · Oligonucleotide |
Top Sponsors (Marketed and Pipeline Drugs) | · Assiut University
· Cairo University · Ain Shams University · Mansoura University · University of Tanta |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Post-Operative Pain (POP) Marketed Drugs Market Segmentation by Mechanisms of Action
The key MoA of the marketed drugs for post-operative pain (POP) includes enzyme inhibitor, receptor agonist, ion channel blocker, receptor antagonist, and transporter inhibitor among others. Most of the marketed drugs followed enzyme inhibitor MoA in 2023 in the post-operative pain (POP)market.
Post-Operative Pain (POP) Marketed Drugs Market Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of Post-Operative Pain (POP) Marketed Drugs
Post-Operative Pain (POP) Pipeline Drugs Market Segmentation by Mechanisms of Action
The key MoA of the drugs in the post-operative pain (POP) pipeline mainly include enzyme inhibitor, receptor agonist, ion channel blocker, receptor antagonist, transporter inhibitor among others. Most of the pipeline drugs for POP followed enzyme inhibitor MoA in 2023.
Post-Operative Pain (POP) Pipeline Drugs Market Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of Post-Operative Pain (POP) Pipeline Drugs
Post-Operative Pain (POP) Pipeline Drugs Market Segmentation by Molecule Types
In 2023, the leading molecule type for Post-Operative Pain (POP) pipeline drugs were small molecules, followed by biologics. The other drugs currently in development are oligonucleotide types.
Post-Operative Pain (POP) Pipeline Drugs Market Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of Post-Operative Pain (POP) Pipeline Drugs
Post-Operative Pain (POP) Marketed and Pipeline Drugs Market – Competitive Landscape
A few of the top sponsors in the post-operative pain (POP) marketed and pipeline drugs market are Assiut University, Cairo University, Ain Shams University, Mansoura University, and the University of Tanta among others. Assiut University sponsored the highest number of trials in 2023.
Post-Operative Pain (POP) Marketed and Pipeline Drugs Market Analysis by Sponsors, 2023 (%)
Buy Full Report for More Sponsor Insights into the Post-Operative Pain (POP) Marketed and Pipeline Drugs Market
Segments Covered in the Report
Post-Operative Pain (POP) Marketed Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Enzyme Inhibitor
- Receptor Agonist
- Receptor Antagonist
- Transporter Inhibitor
- Ion Channel Blocker
Post-Operative Pain (POP) Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Enzyme Inhibitor
- Receptor Agonist
- Ion Channel Blocker
- Receptor Antagonist
- Transporter Inhibitor
Post-Operative Pain (POP) Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Small Molecule
- Biologic
- Oligonucleotide
Scope
The key components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Understand the trends shaping and driving the Post-Operative Pain (POP)market to develop business strategies.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Post-Operative Pain (POP)market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
Which was the leading MoA for post-operative pain (POP) marketed drugs in 2023?
Most of the drugs followed enzyme inhibitor MoA in 2023 in the post-operative pain (POP) drugs market.
-
Which was the leading MoA for post-operative pain (POP) pipeline drugs in 2023?
Most of the drugs followed enzyme inhibitor MoA in 2023 in the post-operative pain (POP) drugs market.
-
Which was the leading molecule type for post-operative pain (POP) pipeline drugs in 2023?
In 2023, most of the drugs in development for post-operative pain (POP) were small molecules.
-
Which are the top sponsors in the post-operative pain (POP) marketed and pipeline drugs market?
A few of the top sponsors in the post-operative pain (POP) marketed and pipeline drugs market are Assiut University, Cairo University, Ain Shams University, Mansoura University and the University of Tanta among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.